Immunosuppressant Monitoring, How Therapeutic Drug Monitoring is Saving Lives
The global therapeutic drug monitoring market is projected to grow from US$ 2.4 billion in 2025 to US$ 4.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 8.9%. According to a report by Persistence Market Research, the rise in chronic disease prevalence, along with the growing need for personalized treatment plans, is driving the demand for precise drug levels to minimize adverse effects and optimize therapeutic outcomes.